Cargando…
Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy
FAP-targeted radiopharmaceuticals represent a breakthrough in cancer imaging and a viable option for therapeutic applications. OncoFAP is an ultra-high-affinity ligand of FAP with a dissociation constant of 680 pM. OncoFAP has been recently discovered and clinically validated for PET imaging procedu...
Autores principales: | Bartoli, Francesco, Elsinga, Philip, Nazario, Luiza Reali, Zana, Aureliano, Galbiati, Andrea, Millul, Jacopo, Migliorini, Francesca, Cazzamalli, Samuele, Neri, Dario, Slart, Riemer H. J. A., Erba, Paola Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416253/ https://www.ncbi.nlm.nih.gov/pubmed/36015106 http://dx.doi.org/10.3390/ph15080958 |
Ejemplares similares
-
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [(68)Ga]Ga-OncoFAP-DOTAGA
por: Backhaus, P., et al.
Publicado: (2021) -
Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging
por: Hu, Kongzhen, et al.
Publicado: (2022) -
Sortase-Mediated Site-Specific Modification of Interleukin-2
for the Generation of a Tumor-Targeting Acetazolamide–Cytokine
Conjugate
por: Gouyou, Baptiste, et al.
Publicado: (2020) -
Nomenclature for radiopharmaceuticals, consultation of your opinion!
por: Elsinga, Philip H.
Publicado: (2017) -
Radiosynthesis, quality control, biodistribution, and infection-imaging study of a new (99m)Tc-labeled ertapenem radiopharmaceutical
por: Naqvi, Syed Ali Raza, et al.
Publicado: (2022)